妊娠期糖尿病而非孕前超重可预测子代20年后心血管代谢标志物
本研究基于纵向队列(ESTER和Arvo Ylppö研究),纳入平均年龄24.1±1.3岁的子代,分为妊娠期糖尿病(GDM)母亲子代组(n=193)、孕前超重/肥胖但糖耐量正常母亲子代组(n=157)和对照组(n=556)。结果显示,GDM母亲子代具有胰岛素抵抗标志物升高和致动脉粥样硬化性血脂谱,部分由混杂因素或当前子代肥胖解释;孕前超重/肥胖与子代糖调节受损相关,但可由混杂因素和/或当前肥胖解释。
要点
- GDM母亲子代成年后空腹血糖和胰岛素升高,但调整后差异减弱。
- GDM母亲子代SHBG、HDL和ApoA1降低,且调整后仍显著。
- 孕前超重/肥胖与子代糖调节受损相关,但由混杂因素或当前肥胖解释。
核心结论
- GDM母亲子代成年后胰岛素抵抗标志物增加,血脂谱更具致动脉粥样硬化性,部分由混杂因素或当前子代肥胖解释。
- 孕前超重/肥胖与子代糖调节受损相关,但可由混杂因素和/或当前肥胖解释。
研究设计与样本
- 纵向队列研究(ESTER Maternal Pregnancy Disorders Study和Arvo Ylppö Longitudinal Study),纳入子代平均年龄24.1±1.3岁。
- 子代分为三组:GDM母亲子代组(OGDM,n=193)、糖耐量正常但孕前超重/肥胖母亲子代组(ONO,n=157)和糖耐量正常且孕前BMI<25 kg/m2母亲子代组(对照组,n=556)。
主要发现
- 与对照组相比,OGDM组和ONO组空腹血糖分别高1.6%(95%CI 0.1%至3.1%)和2.3%(95%CI 0.5%至4.3%),胰岛素分别高12.7%(95%CI 4.4%至21.9%)和8.7%(95%CI 0.2%至17.8%)。
- 调整混杂因素和/或当前子代特征(包括BMI或体脂百分比)后,上述差异减弱至无统计学意义。
- OGDM组SHBG较低(男性-12.4%,95%CI -20.2%至-3.9%;女性-33.2%,95%CI -46.3%至-16.8%),HDL较低(-6.6%,95%CI -10.9%至-2.2%),ApoA1较低(-4.5%,95%CI -7.5%至-1.4%),这些差异调整后仍显著。
- 心率和其他生物标志物在各组间相似。
临床怎么用
- 对于GDM母亲子代,应关注胰岛素抵抗和致动脉粥样硬化血脂谱的筛查。
- 孕前超重/肥胖母亲子代的糖代谢异常风险可能主要由当前肥胖介导,干预子代肥胖可能有益。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Maternal gestational diabetes mellitus (GDM) and prepregnancy overweight/obesity [body mass index (BMI) ≥25 kg/m2] might adversely affect offspring cardiometabolic health. OBJECTIVE: To assess the associations between maternal GDM and prepregnancy overweight/obesity with adult offspring cardiometabolic risk factors. DESIGN: Longitudinal cohort study (ESTER Maternal Pregnancy Disorders Study and the Arvo Ylppö Longitudinal Study). SETTING: Province of Uusimaa and Northern Finland. PARTICIPANTS: At a mean age of 24.1 ± 1.3 years, we classified offspring as offspring of mothers with GDM regardless of the prepregnancy BMI (OGDM; n = 193); normoglycemic mothers with prepregnancy overweight/obesity (ONO; n = 157); and normoglycemic mothers with prepregnancy BMI <25 kg/m2 (controls; n = 556). MAIN OUTCOME MEASURES: We assessed the cardiometabolic biomarkers from blood and measured the blood pressure at rest and heart rate. RESULTS: Compared with the controls, the OGDM and ONO groups had greater fasting glucose (1.6%; 95% CI, 0.1% to 3.1%; and 2.3%; 95% CI, 0.5% to 4.3%, respectively) and insulin (12.7%; 95% CI, 4.4% to 21.9%; and 8.7%; 95% CI, 0.2% to 17.8%). These differences attenuated to nonsignificance when adjusted for confounders and/or current offspring characteristics, including BMI or body fat percentage. The OGDM group had lower SHBG (men, -12.4%; 95% CI, -20.2% to -3.9%; women, -33.2%; 95% CI, -46.3% to -16.8%), high-density lipoprotein (-6.6%; 95% CI, -10.9% to -2.2%), and apolipoprotein A1 (-4.5%; 95% CI, -7.5% to -1.4%). These differences survived the adjustments. The heart rate and other biomarkers were similar among the groups. CONCLUSIONS: Adult offspring of mothers with GDM have increased markers of insulin resistance and a more atherogenic lipid profile. These were only partly explained by confounders or current offspring adiposity. Maternal prepregnancy overweight/obesity was associated with impaired offspring glucose regulation, which was explained by confounders and/or current adiposity.
引用
- Kaseva N, Vääräsmäki M, Sundvall J, et al. Gestational Diabetes But Not Prepregnancy Overweight Predicts for Cardiometabolic Markers in Offspring Twenty Years Later. J Clin Endocrinol Metab. 2019. PMID: 30835282. doi:10.1210/jc.2018-02743
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。